26.10.2017 13:30:00

Maple Leaf Foods Reports Third Quarter 2017 Financial Results

TSX: MFI
www.mapleleaffoods.com

MISSISSAUGA, ON, Oct. 26, 2017 /CNW/ - Maple Leaf Foods Inc. (TSX: MFI) today reported its financial results for the third quarter, September 30, 2017.

  • Robust sales and volume growth
  • Continued earnings growth, contributing to Free Cash Flow
  • Balanced portfolio offset the spike in raw material costs

Financial Highlights

Third quarter sales increased 6.6% to $908.4 million and Adjusted Earnings per Share(1)increased 21.9% to $0.39 compared to the same quarter last year. Adjusted EBITDA Margin(2) for the quarter was 10.6%, while Free Cash Flow(3) increased to $154.3 million.

For the nine months ended September 30, 2017, sales increased 5.7% and Adjusted Earnings per Share increased 22.8%. Adjusted EBITDA Margin was 10.9% while Free Cash Flow was $204.2 million.

Measure(i)


Three months ended September 30,

Nine months ended September 30,

(Unaudited)


2017

2016

% Change


2017

2016

Sales


908.4

852.1

6.6%


2,645.4

2,503.6

Net Earnings


37.6

31.8

18.2%


105.0

105.5

Adjusted Operating Earnings(4)


65.2

61.5

6.0%


199.2

175.6

Adjusted EBITDA Margin


10.6%

10.3%

30 bps


10.9%

10.3%

Basic Earnings per Share


0.29

0.24

20.8%


0.81

0.78

Adjusted Earnings per Share


0.39

0.32

21.9%


1.13

0.92

Free Cash Flow


154.3

146.7

5.2%


204.2

208.1

(i) All financial measures in millions of dollars except Adjusted EBITDA Margin and Basic and Adjusted Earnings per Share.


Note:  Several items are excluded from the discussions of underlying earnings performance as they are not representative of ongoing operational activities. Refer to the section entitled Reconciliation of Non-IFRS Financial Measures at the end of this news release for a description and reconciliation of all non-IFRS financial measures.

 

"We continued to deliver year-over-year sales and earnings growth in the third quarter, benefiting from our balanced portfolio which offset a sharp spike in raw material costs and the margin compression we expected from this," said Michael H. McCain, President and CEO.  "We are accelerating profitable growth by leveraging our leadership in sustainability and executing on our strategies, which provides significant market differentiation and growth opportunities."

Sales and Earnings

The Company's products include value-added prepared meats, lunch kits and snacks, value-added fresh pork and poultry products and refrigerated plant protein products sold under flagship national brands such as Maple Leaf®, Maple Leaf Prime®, Maple Leaf Natural Selections®, Schneiders®, Schneiders® Country Naturals®, Mina® and Lightlife®.

Sales for the third quarter increased 6.6% to $908.4 million or 5.8% after adjusting for the impact of foreign exchange and acquisitions compared to last year. Higher sales across the portfolio benefited from improved volumes, as well as the addition of Lightlife.

Sales for the first nine months increased 5.7% to $2,645.4 million or 4.6% after adjusting for the impact of foreign exchange and acquisitions.

Net earnings for the third quarter increased to $37.6 million ($0.29 per basic share) compared to $31.8 million ($0.24 per basic share) last year. Sales growth across the business contributed to earnings in the quarter. Robust performance in the value-added fresh portfolio was partially offset by margin compression in prepared meats related to high raw material costs. The Company implemented pricing action during the latter part of the third quarter to address the impact of higher input costs. Net earnings were also impacted by a one-time gain on the sale of a legacy plant, higher restructuring costs and a change in the fair value of biological assets. For the first nine months, net earnings were $105.0 million ($0.81 per basic share) compared to $105.5 million ($0.78 per basic share) last year. Year to date results were also impacted by non routine items in other income, which are excluded in calculating Adjusted Operating Earnings below. 

Adjusted Operating Earnings increased to $65.2 million compared to $61.5 million last year. Increased sales across the business contributed to earnings growth in the quarter. Earnings performance in the value-added fresh portfolio was partially offset by margin compression in prepared meats related to high raw material costs in the period. The one-time gain on the sale of a legacy plant, higher restructuring costs and a change in the fair value of biological assets have been excluded in arriving at Adjusted Operating Earnings.

Adjusted Operating Earnings in the first nine months was $199.2 million compared to $175.6 million last year.

Other Matters

On October 25, 2017, the Board of Directors approved a dividend of $0.11 per share payable December 29, 2017 to shareholders of record at the close of business December 8, 2017. Based on the current number of shares outstanding, it is estimated that $0.094 per share of the total dividend to be paid will be considered an Eligible Dividend for the "Enhanced Dividend Tax Credit System". The final amount of the dividend that is considered an Eligible Dividend will be confirmed on the Company's website on or before December 29, 2017.

Conference Call

An investor presentation related to the Company's third quarter financial results is available at www.mapleleaffoods.com and can be found under Investor Information on the Investors page. A conference call will be held at 2:30 p.m. EDT on October 26, 2017, to review Maple Leaf Foods' third quarter financial results. To participate in the call, please dial 416-340-2218 or 1-800-273-9672. For those unable to participate, playback will be made available an hour after the event at 905-694-9451 or 1-800-408-3053 (Passcode:4460402#).

A webcast presentation of the third quarter financial results will also be available at:

https://edge.media-server.com/m6/p/q9xujowy.

The Company's full unaudited condensed consolidated interim financial statements and related Management's Discussion and Analysis are available on the Company's website.

Reconciliation of Non-IFRS Financial Measures

The Company uses the following non-IFRS measures: Adjusted Operating Earnings, Adjusted Earnings per Share, Adjusted EBITDA, and Free Cash Flow. Management believes that these non-IFRS measures provide useful information to investors in measuring the financial performance of the Company. These measures do not have a standardized meaning prescribed by IFRS and therefore they may not be comparable to similarly titled measures presented by other publicly traded companies and should not be construed as an alternative to other financial measures determined in accordance with IFRS.

Adjusted Operating Earnings








($ thousands)


Three months ended September 30,

Nine months ended September 30,

(Unaudited)


2017

2016

2017

2016

Net earnings


$

37,578

$

31,828

$

105,025

$

105,478

Income taxes


11,939

11,777


38,039


39,210

Earnings before income taxes


$

49,517

$

43,605

$

143,064

$

144,688

Interest expense and other financing costs


1,320

2,819


3,892


5,136

Other expense (income)


(12,764)

(4,621)


(8,928)


(1,429)

Restructuring and other related costs


5,627

542


17,103


2,344

Earnings from operations


$

43,700

$

42,345

$

155,131

$

150,739

Decrease in the fair value of biological assets(5)


20,645

41,617


26,362


41,909

Unrealized loss (gain) on derivative contracts(5)


807

(22,446)


17,695


(17,084)

Adjusted Operating Earnings


$

65,152

$

61,516

$

199,188

$

175,564















Adjusted Earnings per Share








($ per share)


Three months ended September 30,

Nine months ended September 30,

(Unaudited)


2017

2016

2017

2016

Basic earnings per share


$

0.29

$

0.24

$

0.81

$

0.78

Restructuring and other related costs(6)


0.03

0.10

0.01

Items included in other expense (income) not






considered representative of ongoing operations(7)


(0.06)

(0.03)

(0.03)

(0.01)

Unrealized loss (gain) on derivative contracts(8)


(0.12)

0.10

(0.09)

Change in the fair value of biological assets(8)


0.12

0.23

0.15

0.23

Adjusted Earnings per Share (9)


$

0.39

$

0.32

$

1.13

$

0.92














Adjusted Earnings Before Interest, Income Taxes, Depreciation, and Amortization





($ thousands)


Three months ended September 30,

Nine months ended September 30,

(Unaudited)


2017

2016

2017

2016

Net earnings


$

37,578

$

31,828

$

105,025

$

105,478

Income taxes


11,939

11,777

38,039

39,210

Earnings before income taxes


$

49,517

$

43,605

$

143,064

$

144,688

Interest expense and other financing costs


1,320

2,819

3,892

5,136

Items included in other expense (income) not






considered representative of ongoing operations(7)


(10,412)

(5,454)

(6,573)

(2,614)

Restructuring and other related costs


5,627

542

17,103

2,344

Change in the fair value of biological assets and






unrealized loss on derivative contracts(8)


21,452

19,171

44,057

24,825

Depreciation and amortization


28,907

27,068

86,038

82,709

Adjusted EBITDA


$

96,411

$

87,751

$

287,581

$

257,088





















Free Cash Flow












($ thousands)


Three months ended September 30,

Nine months ended September 30,

(Unaudited)


2017

2016

2017

2016

Cash provided by operating activities


$

186,107

$

176,200

$

283,247

$

285,043

Additions to long-term assets


(31,816)

(29,522)

(79,053)

(76,975)

Free Cash Flow


$

154,291

$

146,678

$

204,194

$

208,068

 

Forward Looking Statements

This document contains, and the Company's oral and written public communications often contain, "forward-looking information" within the meaning of applicable securities law. These statements are based on current expectations, estimates, forecasts, and projections about the industries in which the Company operates, as well as beliefs and assumptions made by Management of the Company. Such statements include, but are not limited to, statements with respect to objectives and goals, in addition to statements with respect to beliefs, plans, objectives, expectations, anticipations, estimates, and intentions. Specific forward-looking information in this document includes, but is not limited to, statements with respect to: the increases in operating efficiencies and cost reductions; expectations regarding the use of derivatives, futures and options; expectations regarding improving efficiencies; the expected use of cash balances; source of funds for ongoing business requirements; capital investments and expectations regarding capital expenditures; expectations regarding the implementation of environmental sustainability initiatives; expectations regarding the adoption of new accounting standards and the impact of such adoption on financial position; expectations regarding pension plan performance and future pension plan liabilities and contributions; expectations regarding levels of credit risk; and expectations regarding outcomes of legal actions. Words such as "expect", "anticipate", "intend", "may", "will", "plan", "believe", "seek", "estimate", and variations of such words and similar expressions are intended to identify such forward-looking information. These statements are not guarantees of future performance and involve assumptions, risks, and uncertainties that are difficult to predict.   

In addition, these statements and expectations concerning the performance of the Company's business in general are based on a number of factors and assumptions including, but not limited to: the condition of the Canadian, U.S., and Japanese economies; the rate of exchange of the Canadian dollar to the U.S. dollar, and the Japanese yen; the availability and prices of raw materials, energy and supplies; product pricing; the availability of insurance; the competitive environment and related market conditions; improvement of operating efficiencies; continued access to capital; the cost of compliance with environmental and health standards; no adverse results from ongoing litigation; no unexpected actions of domestic and foreign governments; and the general assumption that none of the risks identified below or elsewhere in this document will materialize. All of these assumptions have been derived from information currently available to the Company, including information obtained by the Company from third-party sources. These assumptions may prove to be incorrect in whole or in part. In addition, actual results may differ materially from those expressed, implied, or forecasted in such forward-looking information, which reflect the Company's expectations only as of the date hereof.  

Factors that could cause actual results or outcomes to differ materially from the results expressed, implied, or forecasted by forward-looking information include, among other things: 

  • risks associated with the Company focusing solely on the protein business;
  • risks related to the Company's decisions regarding any potential return of capital to shareholders;
  • risks associated with the concentration of production in fewer facilities;
  • risks associated with the availability of capital;
  • risks associated with changes in the Company's information systems and processes;
  • risks associated with cyber threats;
  • risks posed by food contamination, consumer liability, and product recalls;
  • risks associated with acquisitions, divestitures, and capital expansion projects;
  • impact on pension expense and funding requirements of fluctuations in the market prices of fixed income and equity securities and changes in interest rates;
  • cyclical nature of the cost and supply of hogs and the competitive nature of the pork market generally;
  • risks related to the health status of livestock;
  • impact of a pandemic on the Company's operations;
  • the Company's exposure to currency exchange risks;
  • ability of the Company to hedge against the effect of commodity price changes through the use of commodity futures and options;
  • impact of changes in the market value of the biological assets and hedging instruments;
  • risks associated with the supply management system for poultry in Canada;
  • risks associated with the use of contract manufacturers;
  • impact of international events on commodity prices and the free flow of goods;
  • risks posed by compliance with extensive government regulation;
  • risks posed by litigation;
  • impact of changes in consumer tastes and buying patterns;
  • impact of extensive environmental regulation and potential environmental liabilities;
  • risks associated with a consolidating retail environment;
  • risks posed by competition;
  • risks associated with complying with differing employment laws and practices, the potential for work stoppages due to non-renewal of collective agreements, and recruiting and retaining qualified personnel;
  • risks associated with pricing the Company's products;
  • risks associated with managing the Company's supply chain; and
  • risks associated with failing to identify and manage the strategic risks facing the Company.

The Company cautions the reader that the foregoing list of factors is not exhaustive. These factors are discussed in more detail under the heading "Risk Factors" in the Company's Management's Discussion and Analysis for the fiscal year ended December 31, 2016 that is available on SEDAR at www.sedar.com. The reader should review such section in detail. Some of the forward-looking information may be considered to be financial outlooks for purposes of applicable securities legislation including, but not limited to, statements concerning future capital expenditures. These financial outlooks are presented to evaluate anticipated future uses of cash flows, and may not be appropriate for other purposes and readers should not assume they will be achieved. The Company does not intend to, and the Company disclaims any obligation to, update any forward-looking information, whether written or oral, or whether as a result of new information, future events or otherwise, except as required by law. Additional information concerning the Company, including the Company's Annual Information Form is available on SEDAR at www.sedar.com.

About Maple Leaf Foods Inc.

Maple Leaf Foods Inc. is a leading consumer protein company, making high quality, innovative products under national brands including Maple Leaf®, Maple Leaf Prime®, Maple Leaf Natural Selections®, Schneiders®, Schneiders® Country Naturals®, Mina® and Lightlife®. Maple Leaf employs approximately 11,500 people and does business in Canada, the U.S. and Asia. The Company is headquartered in Mississauga, Ontario and its shares trade on the Toronto Stock Exchange (MFI).

Footnote Legend

  • Adjusted Earnings per Share, a non-IFRS measure, is used by Management to evaluate financial operating results. It is defined as basic earnings per share and is adjusted on the same basis as Adjusted Operating Earnings. Please refer to the section entitled Non-IFRS Financial Measures in the Company's 2017 third quarter Management's Discussion and Analysis.
  • Adjusted EBITDA, a non-IFRS measure, is calculated as earnings before interest and income taxes plus depreciation and intangible asset amortization, adjusted for items that are not considered representative of ongoing operational activities of the business, and items where the economic impact of the transactions will be reflected in earnings in future periods when the underlying asset is sold or transferred. Adjusted EBITDA Margin is calculated as Adjusted EBITDA divided by sales. Please refer to the section entitled Non-IFRS Financial Measures in the Company's 2017 third quarter Management's Discussion and Analysis.
  • Free Cash Flow, a non-IFRS measure, is used by Management to evaluate cash flow after investing in the maintenance or expansion of the Company's asset base. It is defined as cash provided by operations, less additions to long-term assets. Please refer to the section entitled Non-IFRS Financial Measures in the Company's 2017 third quarter Management's Discussion and Analysis.
  • Adjusted Operating Earnings, a non-IFRS measure, is used by Management to evaluate financial operating results. It is defined as earnings before income taxes adjusted for items that are not considered representative of ongoing operational activities of the business and items where the economic impact of the transactions will be reflected in earnings in future periods when the underlying asset is sold or transferred. Please refer to the section entitled Non-IFRS Financial Measures in the Company's 2017 third quarter Management's Discussion and Analysis.
  • Unrealized gains/losses on derivative contracts is reported within cost of sales in the Company's 2017 third quarter unaudited condensed consolidated interim financial statements. For biological assets information, please refer to Note 6 of the Company's 2017 third quarter unaudited condensed consolidated interim financial statements.
  • Includes per share impact of restructuring and other related costs, net of tax.
  • Primarily includes acquisition related costs, interest income and gains/losses associated with investment properties and assets held for sale, net of tax.  
  • Includes per share impact of the change in unrealized losses on derivative contracts and the change in fair value of biological assets, net of tax.
  • May not add due to rounding.
  • Consolidated Interim Balance Sheets

    (In thousands of Canadian dollars)


    As at September 30,
    2017

    As at September 30,
    2016

    As at December 31,
    2016



    (Unaudited)

    (Unaudited)







    (Restated)(iii)



    ASSETS








    Current assets









    Cash and cash equivalents


    $

    209,850

    $

    444,348

    $

    403,621


    Accounts receivable


    131,394

    120,666

    127,749


    Notes receivable


    29,008

    33,842

    32,485


    Inventories


    278,143

    273,384

    261,719


    Biological assets


    86,083

    65,242

    111,445


    Prepaid expenses and other assets


    29,508

    11,244

    30,372


    Assets held for sale


    4,712

    4,837



    $

    763,986

    $

    953,438

    $

    972,228


    Property and equipment


    1,091,581

    1,080,696

    1,085,275


    Investment property


    1,901

    2,063

    1,929


    Employee benefits


    15,609

    10,311


    Other long-term assets


    5,749

    7,200

    6,557


    Deferred tax asset


    21,480


    Goodwill


    552,231

    428,236

    428,236


    Intangible assets


    159,384

    129,546

    128,085


    Total assets


    $

    2,590,441

    $

    2,622,659

    $

    2,632,621








    LIABILITIES AND EQUITY







    Current liabilities








    Accounts payable and accruals


    $

    288,813

    $

    268,030

    $

    256,163


    Provisions


    14,539

    16,451

    11,889


    Current portion of long-term debt


    794

    711

    794


    Income taxes payable


    4,408

    8,668

    9,544


    Other current liabilities


    29,908

    8,140

    96,857



    $

    338,462

    $

    302,000

    $

    375,247


    Long-term debt


    8,494

    9,269

    9,119


    Employee benefits


    114,396

    160,261

    108,730


    Provisions


    11,337

    13,003

    16,555


    Other long-term liabilities


    12,882

    15,045

    12,654


    Deferred tax liability


    57,351

    22,293


    Total liabilities


    $

    542,922

    $

    499,578

    $

    544,598








    Shareholders' equity







    Share capital


    $

    841,020

    $

    884,431

    $

    853,633

    Retained earnings


    1,233,903

    1,229,297

    1,247,737

    Contributed surplus


    19,855

    Accumulated other comprehensive (loss) income


    (6,443)

    4,647

    1,619

    Treasury stock


    (20,961)

    (15,149)

    (14,966)

    Total shareholders' equity


    $

    2,047,519

    $

    2,123,081

    $

    2,088,023

    Total liabilities and equity


    $

    2,590,441

    $

    2,622,659

    $

    2,632,621

     

    Consolidated Interim Statements of Net Earnings

    (In thousands of Canadian dollars, except
    share amounts)

    Three months ended September 30,

    Nine months ended September 30,

    (Unaudited)

    2017

    2016

    2017

    2016










    Sales

    $

    908,359

    $

    852,099

    $

    2,645,417

    $

    2,503,634

    Cost of goods sold

    778,115

    731,110

    2,233,799

    2,117,504

    Gross margin

    $

    130,244

    $

    120,989

    $

    411,618

    $

    386,130

    Selling, general and administrative expenses

    86,544

    78,644

    256,487

    235,391

    Earnings before the following:

    $

    43,700

    $

    42,345

    $

    155,131

    $

    150,739

    Restructuring and other related costs

    (5,627)

    (542)

    (17,103)

    (2,344)

    Other income (expense)

    12,764

    4,621

    8,928

    1,429

    Earnings before interest and income taxes

    $

    50,837

    $

    46,424

    $

    146,956

    $

    149,824

    Interest expense and other financing costs

    1,320

    2,819

    3,892

    5,136

    Earnings before income taxes

    $

    49,517

    $

    43,605

    $

    143,064

    $

    144,688

    Income taxes

    11,939

    11,777

    38,039

    39,210

    Net earnings

    $

    37,578

    $

    31,828

    $

    105,025

    $

    105,478










    Earnings per share:










    Basic earnings per share

    $

    0.29

    $

    0.24

    $

    0.81

    $

    0.78


    Diluted earnings per share

    $

    0.29

    $

    0.23

    $

    0.79

    $

    0.76

    Weighted average number of shares (millions)






    Basic

    128.1

    134.3

    129.2

    134.4


    Diluted

    131.4

    137.7

    132.6

    137.9

     

    Consolidated Interim Statements of Other Comprehensive Income (Loss)

    (In thousands of Canadian dollars)

    Three months ended September 30,

    Nine months ended September 30,

    (Unaudited)

    2017

    2016

    2017

    2016










    Net earnings

    $

    37,578

    $

    31,828

    $

    105,025

    $

    105,478

    Other comprehensive income (loss)










    Actuarial gains (losses) that will not be










    reclassified to profit or loss











    (Net of tax of $6.3 million and $0.1 million;











    2016: $8.3 million and $1.1 million)

    $

    17,952

    $

    23,621

    $

    391

    $

    (3,147)

    Items that are or may be reclassified









    subsequently to profit or loss:










    Change in accumulated foreign currency










    translation adjustment











    (Net of tax of $0.0 million; 2016:











    $0.0 million)

    $

    (7,727)

    $

    624

    $

    (14,912)

    $

    1,037


    Change in unrealized (losses) gains on 










    cash flow hedges











    (Net of tax of $0.2 million and $2.4 million;







    2016: $1.2 million and $1.4 million)

    (508)

    (3,309)

    6,850

    4,024

    Total items that are or may be reclassified









    subsequently to profit or loss

    $

    (8,235)

    $

    (2,685)

    $

    (8,062)

    $

    5,061

    Total other comprehensive income (loss)

    $

    9,717

    $

    20,936

    $

    (7,671)

    $

    1,914

    Comprehensive income

    $

    47,295

    $

    52,764

    $

    97,354

    $

    107,392

     

    Consolidated Interim Statements of Changes in Total Equity





    Accumulated other







    comprehensive income







    (loss)(i)








    Unrealized







    Foreign

    gains and







    currency

    losses on



    (In thousands of Canadian dollars)

    Share

    Retained

    Contributed

    translation

    cash flow

    Treasury

    Total

    (Unaudited)

    capital

    earnings

    surplus

    adjustment

    hedges

    stock

    equity

    Balance as at December 31, 2016

    $

    853,633

    $

    1,247,737

    $

    $

    2,116

    $

    (497)

    $

    (14,966)

    $

    2,088,023


    Net earnings

    105,025

    105,025


    Other comprehensive income (loss)(ii)

    391

    (14,912)

    6,850

    (7,671)


    Dividends declared ($0.33 per share)

    (42,677)

    (42,677)


    Share-based compensation expense

    16,508

    16,508


    Deferred taxes on share-based compensation

    3,750

    3,750


    Repurchase of shares

    (18,543)

    (47,755)

    (20,258)

    (86,556)


    Exercise of stock options

    5,930

    5,930


    Settlement of share-based compensation

    (28,818)

    16,005

    (12,813)


    Shares purchased by RSU trust

    (22,000)

    (22,000)

    Balance as at September 30, 2017

    $

    841,020

    $

    1,233,903

    $

    $

    (12,796)

    $

    6,353

    $

    (20,961)

    $

    2,047,519





















    Accumulated other







    comprehensive income







    (loss)(i)








    Unrealized







    Foreign

    gains and







    currency

    losses on



    (In thousands of Canadian dollars)

    Share

    Retained

    Contributed

    translation

    cash flow

    Treasury

    Total

    (Unaudited)

    capital

    earnings

    surplus

    adjustment

    hedges

    stock

    equity

    Balance as at December 31, 2015(iii)

    $

    882,770

    $

    1,161,047

    $

    $

    2,506

    $

    (2,920)

    $

    (2,086)

    $

    2,041,317


    Net earnings

    105,478

    105,478


    Other comprehensive income (loss)(ii)

    (3,147)

    1,037

    4,024

    1,914


    Dividends declared ($0.27 per share)

    (36,381)

    (36,381)


    Share-based compensation expense

    19,059

    19,059


    Deferred taxes on share-based compensation

    2,800

    2,800


    Repurchase of shares

    2,300

    (1,648)

    652


    Exercise of stock options

    1,661

    1,661


    Settlement of share-based compensation

    (356)

    38

    (318)


    Shares purchased by RSU trust

    (13,101)

    (13,101)

    Balance at September 30, 2016(iii)

    $

    884,431

    $

    1,229,297

    $

    19,855

    $

    3,543

    $

    1,104

    $

    (15,149)

    $

    2,123,081

    (i)    

    Items that are or may be subsequently reclassified to profit or loss.

    (ii)    

    Included in other comprehensive income (loss) is the change in actuarial gains and losses that will not be reclassified to profit or loss and has been reclassified to retained earnings.

    (iii)    

    Restated, see Note 2 (d) of the Company's 2017 third quarter unaudited condensed consolidated interim financial statements.

     

    Consolidated Interim Statements of Cash Flows

    (In thousands of Canadian dollars)

    Three months ended September 30,

    Nine months ended September 30,

    (Unaudited)

    2017

    2016

    2017

    2016

    CASH PROVIDED BY (USED IN):









    Operating activities










    Net earnings

    $

    37,578

    $

    31,828

    $

    105,025

    $

    105,478


    Add (deduct) items not affecting cash:







    Change in fair value of biological assets

    20,645

    41,617

    26,362

    41,909



    Depreciation and amortization

    28,916

    27,078

    86,066

    84,075



    Share-based compensation

    4,666

    6,241

    16,508

    19,059



    Deferred income taxes

    11,550

    10,731

    34,031

    36,111



    Income tax current

    389

    1,046

    4,008

    3,099



    Interest expense and other financing costs

    1,320

    2,819

    3,892

    5,136



    Gain on sale of long-term assets

    (8,174)

    (5,515)

    (8,684)

    (4,753)



    Change in fair value of non-designated derivative







    financial instruments

    1,088

    (23,488)

    14,905

    (20,449)



    Impairment of assets (net of reversals)

    3,776

    1,171

    3,776

    2,193


    Change in net pension liability

    5,458

    6,691

    897

    19,280


    Net income taxes paid

    (2,523)

    (610)

    (8,888)

    (4,151)


    Interest paid

    (955)

    (640)

    (2,605)

    (2,913)


    Change in provision for restructuring and other






    related costs

    4,177

    (3,765)

    9,121

    (17,527)


    Change in derivatives margin

    12,973

    37,466

    (1,151)

    24,517


    Other

    (5,021)

    118

    (4,938)

    3,038


    Change in non-cash working capital

    70,244

    43,412

    4,922

    (9,059)

    Cash provided by operating activities

    $

    186,107

    $

    176,200

    $

    283,247

    $

    285,043

    Financing activities










    Dividends paid

    $

    (14,147)

    $

    (12,151)

    $

    (42,677)

    $

    (36,381)


    Net decrease in long-term debt

    (666)

    (560)

    (944)

    (852)


    Exercise of stock options

    418

    5,930

    1,661


    Repurchase of shares

    (42,398)

    (153,810)

    (11,922)


    Payment of deferred financing fees

    (483)

    (691)

    (625)

    (1,781)


    Purchase of treasury stock

    (6,000)

    (7,500)

    (22,000)

    (13,101)

    Cash used in financing activities

    $

    (63,276)

    $

    (20,902)

    $

    (214,126)

    $

    (62,376)

    Investing activities










    Additions to long-term assets

    $

    (31,816)

    $

    (29,522)

    $

    (79,053)

    $

    (76,975)


    Acquisition of business, net of cash acquired

    (199,440)


    Proceeds from sale of long-term assets

    14,015

    5,815

    15,601

    6,387

    Cash used in investing activities

    $

    (17,801)

    $

    (23,707)

    $

    (262,892)

    $

    (70,588)

    Increase (decrease) in cash and cash equivalents

    $

    105,030

    $

    131,591

    $

    (193,771)

    $

    152,079

    Cash and cash equivalents, beginning of period

    104,820

    312,757

    403,621

    292,269

    Cash and cash equivalents, end of period

    $

    209,850

    $

    444,348

    $

    209,850

    $

    444,348

     

    SOURCE Maple Leaf Foods Inc.

    Nachrichten zu Microfinancial Incmehr Nachrichten

    Keine Nachrichten verfügbar.

    Analysen zu Microfinancial Incmehr Analysen

    Eintrag hinzufügen
    Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
    Es ist ein Fehler aufgetreten!